(TCAF) T. Rowe Price - Overview
Etf: Large-Cap, U.S., Equity, ETF
Dividends
| Dividend Yield | 0.50% |
| Yield on Cost 5y | 0.76% |
| Yield CAGR 5y | 64.45% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 15.8% |
| Relative Tail Risk | 4.72% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.40 |
| Alpha | -4.50 |
| Character TTM | |
|---|---|
| Beta | 0.874 |
| Beta Downside | 0.861 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.37% |
| CAGR/Max DD | 1.00 |
Description: TCAF T. Rowe Price January 08, 2026
The T. Rowe Price Large-Blend ETF (NYSE ARCA:TCAF) commits at least 80% of its net assets-including any investment-purpose borrowings-to equity securities, primarily large-cap U.S. stocks. While it can hold companies of any market-cap, the portfolio typically leans toward large-cap names and may overweight the information-technology and healthcare sectors, resulting in a non-diversified exposure.
As of the latest filing, TCAF carries an expense ratio of 0.30% and manages roughly $1.2 billion in assets, with a 30-day SEC yield of 1.45%. Its performance closely tracks the S&P 500 (beta ≈ 1.05), reflecting broader market dynamics; however, sector-specific drivers such as U.S. tech earnings growth and healthcare spending trends can cause noticeable deviation from the benchmark.
If you’re looking to deepen your analysis, a quick check on ValueRay’s platform can surface additional risk metrics and comparative analytics for TCAF and its peers.
What is the price of TCAF shares?
Over the past week, the price has changed by -1.60%, over one month by -2.89%, over three months by -0.58% and over the past year by +9.92%.
Is TCAF a buy, sell or hold?
What are the forecasts/targets for the TCAF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 41.1 | 9.2% |
TCAF Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 6.46b USD (6.46b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 6.46b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 6.46b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.14% (E(6.46b)/V(6.46b) * Re(9.14%) + (debt-free company))
Discount Rate = 9.14% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)